Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,120,206
+$1,710,189 QoQ
Shares Held
38,866
+61.7% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $73,564,946 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
361,944 | $42,785,398 | |
| 2 | VTRS |
Viatris Inc
|
681,711 | $9,209,914 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,720 | $5,763,765 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
38,866 | $5,120,206 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
79,787 | $2,403,183 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
62,931 | $1,505,938 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
63,099 | $1,309,935 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
94,309 | $1,306,179 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,120,206 | 38,866 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,410,017 | 24,043 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,128,789 | 22,288 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,881,316 | 22,924 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,685,257 | 24,279 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,125,577 | 22,898 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,690,726 | 32,032 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,903,736 | 50,147 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,174,481 | 37,518 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,813,002 | 28,939 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,399,649 | 39,108 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,177,112 | 44,296 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,239,193 | 41,881 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,033,917 | 42,146 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,619,815 | 43,497 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,608,756 | 47,279 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,370,187 | 57,282 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,296,040 | 62,182 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,633,081 | 58,733 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,844,552 | 60,055 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,954,789 | 50,949 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,727,893 | 38,893 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,706,102 | 38,541 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,431,684 | 44,522 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,491,167 | 40,337 | Shares | Defined | 2020-06-02 | |
| No filing history on record for this holder in this stock. | ||||||